View of THERAPEUTIC OUTCOMES ON IL-17 LEVELS WITH CD20 VERSUS TNF-Α INHIBITORS IN RHEUMATOID ARTHRITIS

Return to Article Details THERAPEUTIC OUTCOMES ON IL-17 LEVELS WITH CD20 VERSUS TNF-Α INHIBITORS IN RHEUMATOID ARTHRITIS Download Download PDF